Addex Therapeutics received CHF 5.7 million in equity financing year to date as well as CHF2.7 million from Indivior in an extended substance use disorder research collaboration.
Addex Therapeutics received CHF 5.7 million in equity financing year to date as well as CHF2.7 million from Indivior in an extended substance use disorder research collaboration.